Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide 3.0 for Visceral Adiposity
NCT03038620Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2017
- Primary completion
- Oct 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in obesity, sponsored by UT Southwestern Medical Center. Started Jan 2017; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03038620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03038620.